Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MeReC Bulletin - COPD

The National Prescribing Centre (NPC) has published a MeReC Bulletin (PDF) that discusses recent safety issues with inhaled treatments for chronic obstructive pulmonary disease (COPD).

The bulletin reviews the benefits of long acting bronchodilators and inhaled corticosteroids (ICS) in patients with COPD and then details the safety issues for long-acting beta2 agonists (LABAs), anticholinergics and ICS individually.

The article concludes with a review of the factors to consider when making treatment choices. This includes a reminder that treatment options should be trialled in patients with COPD and discontinued if there is no benefit.

Action: Clinicians involved in the management of patients with COPD will find this bulletin useful and informative.

Share 'MeReC Bulletin - COPD' on Email Share 'MeReC Bulletin - COPD' on Delicious Share 'MeReC Bulletin - COPD' on Digg Share 'MeReC Bulletin - COPD' on Facebook Share 'MeReC Bulletin - COPD' on reddit Share 'MeReC Bulletin - COPD' on Twitter


No Comments to “MeReC Bulletin - COPD”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.